A Trial for a Personalized Medication Management Platform to Improve Medication Adherence

Taiwan has attracted much attention for its National Health Insurance (NHI) and healthcare system around the world with many countries in Europe and the United States using it as a benchmark. However, increasing medication costs over the past two years account for more than 25% of total expenditure, surpassing every OECD member and mounting increasing pressure on the NHI. Nevertheless, patient medication adherence is relatively low. Thus, the investigators assessed the effectiveness of a personalized medication management system for improving the medication adherence for patients, in order to save long term medication costs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patients Take Medicine Behavior Health Behavior Medication Adherence Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Design, Setting and Patients: The investigators developed a mobile personalized medication management platform (PMMP) to reduce delayed and missed medications. The investigators conducted a randomized control trial in medical centers of northern Taiwan from January 2010 to July 2012 using 1198 participants that missed or delayed their medications during past three days. They received a minimum 7-day to 14-day maximum medication prescription.

Interventions: Patients were randomized into a control group which non-received any SMS reminder for medication using and an intervention group which received a SMS reminder everyday in mobile devices.

Primary Outcome(s) and Measure(s): The primary outcomes were compared patient medication adherence among experimental and control groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Delayed or forgot to take medications over the last 3 days
Received a min. 7-day medication prescription
Able to receive SMS using mobile phones / devices
20 years or older
Having intention to receive active treatment

Exclusion criteria

Unable to receive SMS via mobile phones
Illiterate and < 20 years of age
Received outpatient prescription drugs for ≤ 7 days
External use, injections and traditional Chinese medicine
Planned to go abroad
Cold, cough, or prescribed with analgesics

Treatment and study plan

Personalized Medication Management Platform for SMS Reminder

Device

The Personalized Medication Management Platform was developed by investigators that integrated with Hospital Information System (HIS) to collect the prescription information of patients and automatically send SMS to remind

Primary outcomes

The proportion of patients in delaying and forgetting medications

Time frame: Patients who participated in this trial will be sent SMS during 7days

Sponsors and collaborators

Lead sponsor

Taipei Medical University

Other

Collaborators

China Medical University, Taiwan
Hwa Hsia Institute of Technology, New Taipei City, Taiwan
National Chung Cheng University
National Science and Technology Council, Taiwan
National Taiwan University
National Tsing Hua University, HsinChu City, Taiwan
National Yang Ming Chiao Tung University
Taipei Medical University WanFang Hospital
Taipei Veterans General Hospital, Taiwan

Registry information

Official study title

Mobile Intelligent Personal Medication Management Platform

Important dates

Study start: 2010
Primary completion: 2012
Study completion: 2012
First posted: Jul 23, 2014
Registry last updated: Jul 23, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed